Dividends & Buybacks ·
ResMed Inc. entered into an accelerated share repurchase agreement with Citibank to buy back $450 million of its…
RMDResmed Inc
ResMed Inc. entered into an accelerated share repurchase agreement with Citibank to buy back $450 million of its common stock on August 31, 2026. The company will pay $450 million on September 3, 2026, receiving an initial delivery of shares equal to 80% of the transaction value based on the closing price on September 2, 2026. Final settlement is scheduled for December 2026 and may occur earlier at Citibank's election. The repurchase is funded by proceeds from the sale of its MatrixCare business and cash on hand, operating under a board-approved authorization for up to 20 million shares established in February 2014. ResMed Inc. operates in the medical technology industry, designing and manufacturing devices for sleep apnea and respiratory care.